02:36 PM EDT, 10/21/2025 (MT Newswires) -- Galapagos (GLPG) shares fell over 8% in recent Tuesday trading after the company said it plans to shutter its cell therapy business as part of an ongoing structural overhaul.

The winding down of the cell therapy segment will lead to the closure of sites in the Netherlands, the US, Switzerland, and China, affecting around 365 employees, according to the company.

Upon completion of the wind-down, the company said it expects to incur 100 million euros ($116 million) to 125 million euros of operating costs from Q4 2025 through 2026 and 150 million euros to 200 million euros of restructuring costs next year.

The overhaul is expected to improve operational efficiencies and enable the company to enter transactions using its cash reserves to build a pipeline of novel therapeutics, according to a statement.

Price: 31.52, Change: -2.87, Percent Change: -8.35